INSTIL BIO INC (TIL) Stock Balance Sheet
NASDAQ:TIL - Nasdaq - US45783C2008 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.66M | 9.20M | 43.70M | 37.60M | 241.70M | |||
| Marketable Securities | 113.69M | 141.16M | 217.20M | 416.50M | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | 3.20M | |||
| Other Current Assets | 12.22M | 10.40M | 8.50M | 9.90M | 1.30M | |||
| Total Current Assets | 132.57M | 160.76M | 269.40M | 464.00M | 246.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 131.25M | 141.07M | 209.30M | 122.00M | 55.30M | |||
| Investments And Advances | 2.56M | 23.16M | N/A | N/A | N/A | |||
| Goodwill | N/A | N/A | 0.00 | 5.70M | 5.70M | |||
| Intangibles | N/A | N/A | 0.00 | 10.10M | 10.10M | |||
| Other Non-Current Assets | 6.18M | 639.00K | 3.40M | 8.10M | 1.70M | |||
| Total Non-Current Assets | 139.99M | 164.87M | 212.70M | 146.00M | 72.90M | |||
| TOTAL ASSETS | 272.56M | 325.63M | 482.10M | 610.00M | 319.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 8.98M | 9.16M | 29.50M | 33.50M | 8.10M | |||
| Accounts Payable | 1.20M | 1.21M | 2.40M | 5.60M | 3.50M | |||
| Other Current Liabilities | 107.00K | 190.00K | 1.00M | 2.30M | 1.70M | |||
| Total Current Liabilities | 10.28M | 10.56M | 32.80M | 41.40M | 13.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 82.17M | 81.43M | 72.40M | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 0.00 | 2.40M | 2.50M | |||
| Other Non-Current Liabilities | 3.78M | 7.82M | 13.40M | 11.00M | 10.90M | |||
| Total Non-Current Liabilities | 85.95M | 89.24M | 85.70M | 13.40M | 13.30M | |||
| TOTAL LIABILITIES | 96.23M | 99.80M | 118.50M | 54.80M | 26.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -643.22M | -580.98M | -424.90M | -201.70M | -44.90M | |||
| Additional Paid In Capital | 820.07M | 807.16M | 789.00M | 757.00M | 5.60M | |||
| Common Shares | 10.00 | 10.00 | 0.00 | 0.00 | 332.00M | |||
| Other Shareholders' Equity | -520.01K | -348.01K | -500.00K | -100.00K | -300.00K | |||
| Shares Outstanding | 6.53M | 6.50M | 130.10M | 129.00M | 125.80M | |||
| Tangible Book Value per Share | 27.02 | 34.72 | 2.79 | 4.18 | -0.44 | |||
| Total Shareholders' Equity | 176.33M | 225.83M | 363.60M | 555.20M | 292.40M | |||
| TOTAL LIABILITIES AND EQUITY | 272.56M | 325.63M | 482.10M | 610.00M | 319.00M | |||
| Statistics | ||||||||
| Debt/Equity | 0.47 | 0.36 | 0.20 | N/A | N/A | |||
| Current Ratio | 12.90 | 15.22 | 8.21 | 11.21 | 18.50 | |||
| Return On Assets (ROA) | -27.58% | -47.93% | -46.29% | -25.70% | -11.83% | |||
| Return On Equity (ROE) | -42.63% | -69.12% | -61.38% | -28.24% | -12.91% | |||
All data in USD , ROIC based on taxRate of 0.21